BIOGEN INC. Operating Income Loss

Quick Answer

BIOGEN INC. reported Operating Income Loss of $2.84 billion for the year ending 2021.

  • BIOGEN INC. showed a decrease of -37.6% in Operating Income Loss from 2020 to 2021.
  • This data is from BIOGEN INC.'s annual report (Form 10-K), filed with the SEC on February 3, 2022.
  • XBRL data for this metric is available from 2007 to 2021 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2008: $296.80 million | Q3 2008: $345.85 million | Q1 2009: $304.96 million | Q2 2009: $222.91 million | Q3 2009: $384.18 million | Q1 2010: $303.69 million | Q2 2010: $395.88 million | Q3 2010: $194.14 million | Q1 2011: $416.28 million | Q2 2011: $410.81 million | Q3 2011: $488.49 million | Q1 2012: $369.37 million | Q2 2012: $505.72 million | Q3 2012: $535.25 million | Q1 2013: $510.53 million | Q2 2013: $662.53 million | Q3 2013: $684.53 million | Q1 2014: $671.35 million | Q2 2014: $988.73 million | Q3 2014: $1.15 billion | Q1 2015: $1.12 billion | Q2 2015: $1.23 billion | Q3 2015: $1.37 billion | Q1 2016: $1.38 billion | Q2 2016: $1.46 billion | Q3 2016: $1.43 billion | Q1 2017: $1.02 billion | Q2 2017: $1.20 billion | Q3 2017: $1.65 billion | Q1 2018: $1.53 billion | Q2 2018: $1.21 billion | Q3 2018: $1.70 billion | Q1 2019: $1.50 billion | Q2 2019: $1.96 billion | Q3 2019: $1.81 billion | Q1 2020: $1.82 billion | Q2 2020: $1.97 billion | Q3 2020: $1.09 billion | Q1 2021: $973.90 million | Q2 2021: $485.70 million | Q3 2021: $794.00 million | Q1 2022: $610.70 million.
  • Over the full 15 years of available data (2007 to 2021), BIOGEN INC.'s Operating Income Loss has grown by 264.3%.
  • Historical annual values: Fiscal year 2021: $2.84 billion | Fiscal year 2020: $4.55 billion | Fiscal year 2019: $7.04 billion | Fiscal year 2018: $5.89 billion | Fiscal year 2017: $5.35 billion | Fiscal year 2016: $5.15 billion | Fiscal year 2015: $4.89 billion | Fiscal year 2014: $3.97 billion | Fiscal year 2013: $2.52 billion | Fiscal year 2012: $1.86 billion | Fiscal year 2011: $1.72 billion | Fiscal year 2010: $1.25 billion | Fiscal year 2009: $1.30 billion | Fiscal year 2008: $1.21 billion | Fiscal year 2007: $779.77 million.
  • Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: